Generic Version of Lexcol XL Now Available

September 17, 2015 – The U.S. Food and Drug Administration approved Mylan’s AB-rated generic to Lexcol XL (fluvastatin sodium extended-release) 80mg tablets. Lescol XL is manufactured by Novartis and belongs to a class of drugs known as HMG-CoA reductase inhibitors, or statins and had been approved in October 2000 for reducing high cholesterol levels. Mylan has already begin shipments and the generic version of Lexcol XL is now available.

Adverse reactions or quality problems experienced with the use of a recalled product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm
• Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

Actual drug patent expiration dates and a availability of new medications are subject to change due to patent litigation, settlement agreements, additional patents, exclusivities, and final FDA approval.  Distribution and availability of new medications at pharmacies may not occur immediately following FDA approval.  Patients are advised to speak with their healthcare professional or pharmacist regarding appropriateness as well as actual availability. All trademarks are the property of their respective owners.

*This is provided for information only.  The reference to any medication above does not mean the medication is covered by your plan.